BCWORLD PHARM's earnings have been declining at an average annual rate of -8.3%, while the Pharmaceuticals industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 5.4% per year.
How BCWORLD PHARM makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A200780 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
79,812
-2,510
17,147
9,410
31 Dec 25
75,800
-4,897
18,357
8,990
30 Sep 25
77,044
-3,765
17,739
8,284
30 Jun 25
75,316
-3,743
17,152
7,587
31 Mar 25
74,334
-4,937
16,622
7,246
31 Dec 24
74,814
-4,433
16,001
7,779
30 Sep 24
72,884
-8,075
15,965
7,690
30 Jun 24
72,959
-6,897
16,262
7,381
31 Mar 24
72,195
859
16,321
6,757
31 Dec 23
75,111
2,634
16,350
6,141
30 Sep 23
76,056
6,240
23,560
-1,616
30 Jun 23
76,213
5,651
23,202
-1,308
31 Mar 23
76,040
481
22,746
306
31 Dec 22
72,703
281
21,296
771
30 Sep 22
68,918
255
12,743
9,180
30 Jun 22
66,489
-644
12,359
9,454
31 Mar 22
63,383
-2,944
11,916
9,135
31 Dec 21
62,079
-1,843
11,712
9,298
30 Sep 21
59,217
-8,508
12,103
10,011
30 Jun 21
57,763
-6,032
11,434
10,976
31 Mar 21
57,071
-1,956
10,427
11,225
31 Dec 20
57,030
-1,580
10,917
10,951
30 Sep 20
56,434
-2,450
10,395
10,761
30 Jun 20
56,034
-1,392
10,213
9,667
31 Mar 20
54,135
-1,972
10,617
8,616
31 Dec 19
51,497
-1,553
9,760
8,444
30 Sep 19
51,440
5,011
9,308
7,393
30 Jun 19
52,492
4,761
9,057
7,324
31 Mar 19
53,823
5,024
8,983
7,500
31 Dec 18
54,792
4,993
8,626
7,241
30 Sep 18
54,722
7,777
8,480
7,211
30 Jun 18
53,044
8,124
8,332
6,896
31 Mar 18
51,008
8,000
8,327
6,464
31 Dec 17
50,207
8,083
8,348
6,650
31 Dec 16
45,658
6,475
9,120
6,557
Quality Earnings: A200780 is currently unprofitable.
Growing Profit Margin: A200780 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A200780 is unprofitable, and losses have increased over the past 5 years at a rate of 8.3% per year.
Accelerating Growth: Unable to compare A200780's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A200780 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (25.5%).
Return on Equity
High ROE: A200780 has a negative Return on Equity (-0.67%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/01 18:03
End of Day Share Price
2026/06/01 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BCWORLD PHARM. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.